-
2023-510178-15-00
5
2024-07-31
High-risk Large B-cell Lymphoma
-
2023-506906-38-00
5
2024-05-23
Follicular Lymphoma
-
2023-508085-15-00
5
2024-05-15
Chronic Obstructive Pulmonary Disease
-
2023-506011-18-00
5
2024-04-17
Vitiligo
-
2023-503288-40-00
5
2024-01-26
Unresectable or Metastatic Melanoma
-
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2023-504743-13-00
4
2022-11-30
Moderately to Severely Active Ulcerative Colitis
-
2023-508869-32-00
5
2022-11-10
Cancer - Plasma cell myeloma recurrent
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma
-
2024-513423-16-00
6
2022-08-25
Asthma
-
2022-502122-41-00
5
2021-05-11
Clear cell renal cancer
-
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
-
2023-505699-31-00
5
2017-01-02
Ulcerative Colitis
-
2023-509197-35-00
5
2024-10-17
Thyroid Eye Disease (TED)
-
2023-505842-24-00
5
2024-05-07
Moderate to Severe Plaque Psoriasis
-
2023-503333-22-00
5
2024-01-15
Moderate to severe controlled asthma according to Step 4 and Step 5 of
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502678-18-00
5
2023-11-07
Type 2 diabetes
-
2022-500777-14-00
4
2023-11-06
Atopic Dermatitis
-
2022-502888-38-00
4
2023-09-25
Atopic dermatitis
-
2022-502024-51-00
5
2023-07-12
Prevention of pregnancy
-
2023-509243-27-00
4
2023-04-12
Moderate-to-Severe Uncontrolled Asthma
-
2024-517612-29-00
11
2023-02-14
acute heart failure